Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism-Reference-Cited by-同舟云学术

Astragaloside IV alleviates myocardial damage induced by type 2 diabetes via improving energy metabolism

Published:2019-10-01 Issue: Volume: Page:
ISSN:1791-2997
Container-title:Molecular Medicine Reports
language:
Short-container-title:Mol Med Report

Author:

Zhang Zhen¹,Wang Jing²,Zhu Yingwei³,Zhang Hui¹,Wang Hongxin¹

Affiliation:

1. Key Laboratory of Cardiovascular and Cerebrovascular Drug Research of Liaoning Province, Jinzhou Medical University, Jinzhou, Liaoning 121001, P.R. China

2. The First Affiliated Hospital, Jinzhou Medical University, Jinzhou, Liaoning 121001, P.R. China

3. Institute of Physical Education, Bohai University, Jinzhou, Liaoning 121013, P.R. China

Publisher

Spandidos Publications

Subject

Cancer Research,Oncology,Genetics,Molecular Biology,Molecular Medicine,Biochemistry

Cited by 20 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Diabetes cardiomyopathy: targeted regulation of mitochondrial dysfunction and therapeutic potential of plant secondary metabolites;Frontiers in Pharmacology;2024-07-09

2. A Review on the Natural Products in Treatment of Diabetic Cardiomyopathy (DCM);Reviews in Cardiovascular Medicine;2024-05-13

3. Saponin monomers: Potential candidates for the treatment of type 2 diabetes mellitus and its complications;Phytotherapy Research;2024-05-07

4. Astragaloside IV attenuates renal tubule injury in DKD rats via suppression of CD36-mediated NLRP3 inflammasome activation;Frontiers in Pharmacology;2024-03-20

5. A systematic review of astragaloside IV effects on animal models of diabetes mellitus and its complications;Heliyon;2024-03